文献速递类风湿关节炎

达标治疗策略对早期类风湿关节炎骨侵蚀进展的影响:一项HR-pQCT研究

Effect of treat-to-target strategies on bone erosion progression in early rheumatoid arthritis: An HR-pQCT study.
PubMed 文献 · Semin Arthritis Rheum · 2018-05-03

该开放标签研究将80例早期类风湿关节炎患者随机分为SDAI≤3.3组(n=37)和DAS28-CRP<2.6组(n=43),治疗1年后63例完成影像分析。两组临床参数、骨侵蚀数目与大小及侵蚀周围骨密度变化相似;事后分析显示未持续达到SDAI缓解及类风湿因子>16U与侵蚀体积增加独立相关,持续SDAI缓解与部分侵蚀修复相关。

要点

  • 更严格的SDAI≤3.3目标与DAS28-CRP<2.6目标在1年时临床结局和骨侵蚀进展上无显著差异。
  • 第6、9、12月未持续达到SDAI缓解(p=0.034)和类风湿因子>16U(p=0.021)是侵蚀体积增加的独立预测因素。
  • 持续达到SDAI缓解与部分骨侵蚀修复相关(p=0.043)。

核心结论

  • 更严格的治疗目标未明显影响1年时的临床治疗结局和骨侵蚀进展,但持续达到SDAI缓解与部分骨侵蚀修复相关。

研究设计与样本

  • 开放标签研究,80例早期类风湿关节炎患者随机接受1年紧密控制治疗,第1组(n=37)目标SDAI≤3.3,第2组(n=43)目标DAS28-CRP<2.6。
  • 在基线和12个月时测量第二掌指关节(MCP2)骨侵蚀的数目和大小及侵蚀周围骨密度,12个月时63例患者完成影像分析。

主要发现

  • 12个月后,两组间临床参数变化、骨侵蚀数目和大小及侵蚀周围骨密度均相似。
  • 事后分析纳入全部63例患者,多因素分析显示第6、9、12月未持续达到SDAI缓解(p=0.034)和类风湿因子>16U(p=0.021)是与侵蚀体积增加相关的独立预测因素。
  • 逻辑回归分析显示达到持续SDAI缓解(p=0.043)与部分侵蚀修复相关。

关键数值与推荐

  • 第1组治疗目标为SDAI≤3.3,第2组治疗目标为DAS28-CRP<2.6。
  • 未持续达到SDAI缓解(p=0.034)和类风湿因子>16U(p=0.021)为侵蚀体积增加的独立预测因素。
  • 持续SDAI缓解与部分侵蚀修复相关(p=0.043)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To investigate the efficacy of two tight-control treatment strategies aimed at simplified disease activity score [SDAI] remission (SDAI ≤ 3.3) compared to DAS28 remission (DAS28 < 2.6) on progression of bone erosions in early rheumatoid arthritis (ERA) patients using high-resolution peripheral quantitative computed tomography (HR-pQCT). METHODS: This was an open-label study in which 80 early RA patients were randomized to receive 1-year of tight-control treatment. Group 1 (n = 37) aimed at SDAI ≤ 3.3 and group 2 (n = 43) aimed at DAS28-CRP < 2.6. The number and size of bone erosions, as well as the bone mineral density (BMD) surrounding bone erosion at the second metacarpophalangeal joint (MCP2), were measured at baseline and 12 months. RESULTS: After 12 months, images were analyzed in 63 patients. Changes in clinical parameters, number and size of bone erosions as well as the BMD surrounding bone erosion between the two treatment groups were similar. Therefore, a post-hoc analysis including all 63 patients was performed to elucidate the independent predictors of erosion progression and repair. Multivariate analysis revealed that not achieving sustained SDAI remission at month 6, 9 and 12 (p = 0.034) and rheumatoid factor >16U (p = 0.021) were independent predictors associated with an increase in erosion volume. Logistic regression analysis showed that achieving sustained SDAI remission (p = 0.043) was associated with partial erosion repair. CONCLUSIONS: Although more stringent treatment target did not notably affect clinical treatment outcome and erosion progression at 1 year, achieving sustained SDAI remission was found to be associated with partial erosion repair.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Yue J, Griffith JF, Xu J, et al. Effect of treat-to-target strategies on bone erosion progression in early rheumatoid arthritis: An HR-pQCT study. Semin Arthritis Rheum. 2018. PMID: 29858113. doi:10.1016/j.semarthrit.2018.05.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。